SynthesisBlood advances2024

Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs.

Connor Prosty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.